Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
69.71
-0.19 (-0.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
Belite Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Belite Bio stock have an average target of 59, with a low estimate of 57 and a high estimate of 60. The average target predicts a decrease of -15.36% from the current stock price of 69.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 12, 2024.
Analyst Ratings
The average analyst rating for Belite Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | -13.93% | Sep 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $59 → $60 | Strong Buy | Maintains | $59 → $60 | -13.93% | Aug 13, 2024 |
| Benchmark | Benchmark | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | -18.23% | Aug 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | -15.36% | Jun 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.75M
EPS This Year
-1.19
from -1.19
EPS Next Year
-0.98
from -1.19
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 52.5M | 91.2M | ||
| Avg | n/a | 12.8M | 57.1M | ||
| Low | n/a | n/a | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 615.6% | ||
| Avg | - | - | 347.6% | ||
| Low | - | - | 92.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.09 | 0.11 | 0.20 | ||
| Avg | -1.19 | -0.98 | -0.54 | ||
| Low | -1.24 | -1.49 | -1.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.